3/25
10:44 am
mdwd
What Makes MediWound (MDWD) a Good Fit for 'Trend Investing' [Yahoo! Finance]
Low
Report
What Makes MediWound (MDWD) a Good Fit for 'Trend Investing' [Yahoo! Finance]
3/24
08:13 am
mdwd
MediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]
Low
Report
MediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]
3/22
11:03 pm
mdwd
MediWound Ltd. (NASDAQ: MDWD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
MediWound Ltd. (NASDAQ: MDWD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/22
08:07 am
mdwd
MediWound Ltd. (NASDAQ: MDWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Low
Report
MediWound Ltd. (NASDAQ: MDWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
3/21
07:17 am
mdwd
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update [Yahoo! Finance]
Medium
Report
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update [Yahoo! Finance]
3/21
07:00 am
mdwd
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
Medium
Report
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
3/14
08:00 am
mdwd
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
Low
Report
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
3/7
06:57 am
mdwd
Retail investors who hold 38% of MediWound Ltd. (NASDAQ:MDWD) gained 15%, institutions profited as well [Yahoo! Finance]
Low
Report
Retail investors who hold 38% of MediWound Ltd. (NASDAQ:MDWD) gained 15%, institutions profited as well [Yahoo! Finance]
3/6
10:34 am
mdwd
MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last? [Yahoo! Finance]
Low
Report
MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last? [Yahoo! Finance]
2/26
11:07 pm
mdwd
MediWound Ltd. (NASDAQ: MDWD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
MediWound Ltd. (NASDAQ: MDWD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/16
01:08 am
mdwd
MediWound Ltd. (NASDAQ: MDWD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
MediWound Ltd. (NASDAQ: MDWD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/15
01:14 pm
mdwd
Burns Market is Projected to Grow During the Study Period (2019–2032), Predicts DelveInsight | Key Players in the Market - Aegle Therapeutics, Skingenix, Inc., Stratatech, MediWound Ltd [Yahoo! Finance]
Low
Report
Burns Market is Projected to Grow During the Study Period (2019–2032), Predicts DelveInsight | Key Players in the Market - Aegle Therapeutics, Skingenix, Inc., Stratatech, MediWound Ltd [Yahoo! Finance]
2/12
12:27 pm
mdwd
MediWound stock climbs 9% on Phase 2 data for wound care treatment [Seeking Alpha]
Medium
Report
MediWound stock climbs 9% on Phase 2 data for wound care treatment [Seeking Alpha]
2/12
07:13 am
mdwd
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study [Yahoo! Finance]
Low
Report
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study [Yahoo! Finance]
2/12
07:00 am
mdwd
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
Low
Report
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
2/7
10:10 pm
mdwd
MediWound Ltd. (NASDAQ: MDWD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
MediWound Ltd. (NASDAQ: MDWD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/5
08:12 am
mdwd
MediWound to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
MediWound to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
2/5
08:00 am
mdwd
MediWound to Participate in Two Upcoming Investor Conferences
Medium
Report
MediWound to Participate in Two Upcoming Investor Conferences
2/1
09:10 am
mdwd
Here's Why We're Not Too Worried About MediWound's (NASDAQ:MDWD) Cash Burn Situation [Yahoo! Finance]
Low
Report
Here's Why We're Not Too Worried About MediWound's (NASDAQ:MDWD) Cash Burn Situation [Yahoo! Finance]
1/21
09:07 am
mdwd
Medical Innovations, Vast Experience Combine To Help Burn Victims In Israel And Worldwide [Forbes]
Medium
Report
Medical Innovations, Vast Experience Combine To Help Burn Victims In Israel And Worldwide [Forbes]
1/16
08:01 am
mdwd
MediWound Ltd. (NASDAQ: MDWD) had its price target raised by analysts at HC Wainwright from $26.00 to $28.00. They now have a "buy" rating on the stock.
Low
Report
MediWound Ltd. (NASDAQ: MDWD) had its price target raised by analysts at HC Wainwright from $26.00 to $28.00. They now have a "buy" rating on the stock.
1/16
01:21 am
mdwd
MediWound Ltd. (NASDAQ: MDWD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
MediWound Ltd. (NASDAQ: MDWD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
1/15
11:19 am
mdwd
MediWound (MDWD)'s Technical Outlook is Bright After Key Golden Cross [Yahoo! Finance]
Low
Report
MediWound (MDWD)'s Technical Outlook is Bright After Key Golden Cross [Yahoo! Finance]
1/9
10:49 am
mdwd
MediWound (MDWD): Strong Industry, Solid Earnings Estimate Revisions [Yahoo! Finance]
Low
Report
MediWound (MDWD): Strong Industry, Solid Earnings Estimate Revisions [Yahoo! Finance]
1/9
07:00 am
mdwd
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns
Medium
Report
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns